logo

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

Elizabeth M Kudlacz

This inventor holds 20 USPTO granted patents, plus 14 CIPO patents, primarily in Allergic Disease Treatment. Top assignees: Hoechst Marion Roussel, Merrell Pharmaceuticals, Inc., Aventis Pharmaceuticals Inc.. Active years: 1996-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth M Kudlacz. Retrieved from https://idiyas.com/inventor/elizabeth-m-kudlacz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 100.0


Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 97(Granted Patents)


Location History:

  • Cincinnati, OH (US) (1996 - 1999)
  • Groton, CT (US) (1999 - 2001)

Company Filing History:

goldMedal8 out of 236 
 
Hoechst Marion Roussel
 patents
silverMedal6 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents
bronzeMedal5 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 1 out of 2 
 
Hoescht Marion Roussel, Inc.
 patents

Years Active: 1996-2001

Loading Chart...
Loading Chart...
Areas of Expertise:
Piperidine Derivatives
Cyclic Carboxamides
Neurokinin A Antagonists
Heterocyclic Compounds
Allergic Diseases
Carboxy Substituted
Pyrrolidine Amides
Piperazine Derivatives
Substituted Benzamides
Acyclic Carboxamide
Piperazinone Derivatives
Alkyldiamine Derivatives
20 patents (USPTO):Explore Patents
1. 6329392 - Substituted piperidines useful for the treatment of allergic diseases (2001-12-11),
2. 6316445 - Carboxy substituted acylic carboxamide derivatives (2001-11-13),
3. 6297259 - Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl) benzamides useful for the treatment of allergic diseases (2001-10-02),
4. 6211199 - Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases (2001-04-03),
5. 6194406 - Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease (2001-02-27),
6. 5998439 - Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides (1999-12-07),
7. 5977139 - Carboxysubstituted cyclic carboxamide derivatives (1999-11-02),
8. 5932571 - Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) (1999-08-03),
9. 5922737 - Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) (1999-07-13),
10. 5864045 - Heterocyclic substituted piperazinone derivatives (1999-01-26),
11. 5861417 - Heterocyclic substituted pyrrolidine amide derivatives (1999-01-19),
12. 5861416 - Substituted pyrrolidin-3-yl-alkyl-piperidines (1999-01-19),
13. 5840726 - Heterocyclic substituted piperazinone derivatives (1998-11-24),
14. 5824690 - Substituted pyrrolidin-3-yl-alkyl-piperidines (1998-10-20),
15. 5672602 - Substituted piperazine derivatives (1997-09-30),

Title: Innovations of Elizabeth M Kudlacz in Cincinnati, OH

Introduction

Elizabeth M Kudlacz is a notable inventor based in Cincinnati, Ohio, recognized for her significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 20 patents, her work focuses on various innovative therapies aimed at addressing allergic diseases.

Latest Patents

Among her latest patents, Kudlacz has developed novel substituted piperidine derivatives, which offer potential treatments for allergic diseases. Additionally, she has created carboxy substituted acyclic carboxamide derivatives, further advancing pharmaceutical options for patients in need.

Career Highlights

Kudlacz has had an impactful career with reputable companies including Hoechst Marion Roussel and Merrell Pharmaceuticals, Inc. Her experience within these organizations has undoubtedly shaped her innovative approach to drug development and her success as an inventor.

Collaborations

Throughout her career, Kudlacz has worked alongside distinguished colleagues such as Timothy Paul Burkholder and George D Maynard. These collaborations have enriched her research and resulted in further advancements in her patented inventions.

Conclusion

Elizabeth M Kudlacz's innovative spirit and dedication to improving healthcare through her inventions have established her as a key figure in the pharmaceutical industry. Her valuable contributions continue to pave the way for future advancements in the treatment of allergic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…